[Executive Summary] Overcoming Manufacturing Challenges for Accelerated Drug Development

New drugs receiving expedited approval have shorter timelines, which can create unique challenges for development and manufacturing. Learn how to leverage the drug development knowledge and build a strategy that maintains the integrity, quality, and timeliness of the manufacturing process.

Download the executive summary to get expert insights on overcoming manufacturing challenges associated with expedited development programs. Learn more about –
  • How to manage stability programs to support accelerated development timeline
  • Fit-for-purpose manufacturing strategies to support accelerated timeline
  • Overcoming hurdles in scale-up and post-launch considerations

Sponsored by: